ERIC KARAS plan to sell securities of ARS PHARMACEUTICALS, INC. under Form 144

ERIC KARAS filed Form 144 to notify SEC of plan to sell 25000 units of ARS PHARMACEUTICALS, INC. securities around 2026-06-12, with aggregate market value of $250,000.00. The total outstanding units is 99303262.0. The amount planned to be sold represents 0.03% of total outstanding units;